Fisher Investments
Unearthing the fees that Fisher charges but doesn’t disclose in some of its TV ads.
Vytorin Cholesterol Pill
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since acquired) over its cholesterol medication Vytorin. The settlement is for a whopping $688 million. The two lawsuits were filed by shareholders of the companies and alleged, among other things, that the companies made false and misleading statements regarding the effectiveness and economic success of the drug in press releases and other public disclosures.
The Latest
Tell the FDA What You Think ‘Healthy’ on Food Labels Should Mean
The deadline to submit a comment on the agency’s new proposed definition is Dec. 28.
Tell Me Why | Downy
Getting rid of old, smelly clothes ain’t nothin’ but a heartbreak.
‘Dishwasher Safe’ Nonstick Pans from Granitestone Diamond
Think twice before sticking nonstick cooking pans in the dishwasher.
What You Should Know About Homes CNL/Smart CNL
This crypto scam has cost hundreds of people thousands of dollars.